Complete side-effect profile
Incidence rates from OASIS-4 phase 3 trial (oral semaglutide 25 mg vs placebo, 64 weeks).
| Side effect | Incidence | Severity | Management |
|---|---|---|---|
| Nausea | 39% | Mild-moderate | Bland diet 2 weeks after each step-up; ginger; eat slowly; Zofran if persistent |
| Diarrhea | 32% | Transient | Hydration; electrolytes; usually resolves at maintenance |
| Vomiting | 21% | Mild | Smaller portions; stop at 70% full; severe = call prescriber |
| Constipation | 20% | Chronic if untreated | 25-35g fiber/day + 80oz water; chia/oats; mag glycinate if needed |
| Decreased appetite | 15% | Expected | Therapeutic effect — eat to target not hunger |
| Abdominal pain | 12% | Mild typical | Severe pain radiating to back = pancreatitis rule-out |
| Dyspepsia / heartburn | 9% | Mild | PPI as needed; avoid large fatty meals at night |
| Fatigue | 7% | Mild | Hydration + protein audit; usually transient |
The fasting-protocol problem
Oral Wegovy requires you to take the pill on an empty stomach with 4 oz of plain water, then wait 30 minutes before food or other drinks. This protocol drives absorption — but it also amplifies nausea in early titration weeks.
Tactic: have a bland, protein-light breakfast scheduled for the 30-minute mark. Plain Greek yogurt + a small handful of berries lands better than eggs + bacon for the first 4 weeks. As you reach maintenance dose and side effects fade, you can return to your preferred breakfast.
Red flags — call your prescriber
Don't white-knuckle these. Call same-day:
- • Vomiting >24 hours, unable to keep fluids down
- • Severe abdominal pain radiating to back (possible pancreatitis)
- • Persistent yellow eyes/skin (possible cholestasis)
- • New lump in neck, hoarseness (possible thyroid)
- • Losing >2 lbs/week consistently (too-fast loss risk)
Side effects vs. other GLP-1s
| Effect | Oral Wegovy 25mg | Wegovy inj 2.4mg | Foundayo 36mg | Zepbound 15mg |
|---|---|---|---|---|
| Nausea | 39% | 44% | 24% | 29% |
| Diarrhea | 32% | 30% | 16% | 21% |
| Vomiting | 21% | 24% | 11% | 10% |
| Discontinuation | 13% | 7% | 12% | 7% |
Oral Wegovy has higher GI side effects than Foundayo or Zepbound — driven primarily by the high 25 mg dose. If you cannot tolerate oral Wegovy, Foundayo (oral, GLP-1 only, ~11% weight loss) is a reasonable alternative.
Frequently asked questions
- How long do oral Wegovy side effects last?
- Most GI side effects peak in week 1-2 of each dose increase and resolve within 2-3 weeks. By maintenance dose (week 13+), most patients have minimal symptoms.
- Does oral Wegovy cause more nausea than injectable Wegovy?
- Yes, slightly. OASIS-4 showed 39% nausea on oral 25 mg vs 44% on injectable 2.4 mg — close, with oral marginally lower. But oral discontinuation rates are higher because the fasting protocol amplifies discomfort.
- Can I take Zofran with oral Wegovy?
- Yes — no interaction. Ondansetron 4 mg PRN is the standard prescription for breakthrough nausea on any GLP-1. Ask your prescriber.
- Does oral Wegovy cause hair loss?
- ~5-7% of patients report hair shedding (telogen effluvium) from rapid weight loss, not the drug. Resolves at 6-9 months once weight stabilizes.
- What is the boxed warning for oral Wegovy?
- Same as injectable: thyroid C-cell tumor risk (rodent studies). Not for patients with personal or family history of medullary thyroid carcinoma or MEN-2 syndrome.
Educational only — not medical advice. Contact your prescriber for side-effect management.